Finance

Lists
ALKEM:NSE
Alkem Laboratories Ltd
5 265,00 ₹
-1,60%
(-85,50) 1D
8 қаз., 13:38:49 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALKEM...
Open
5 407,00 ₹
High
5 407,00 ₹
Low
5 239,00 ₹
Mkt. cap
620,82 млрд
Avg. vol.
148,86 м.
Volume
140,99 м.
Dividend
1,01%
Quarterly dividend
13,25 ₹
Ex-dividend date
2026 ж. 07 там.
P/E ratio
29,18
52-wk high
5 933,50 ₹
52-wk low
5 051,00 ₹
EPS
180,45 ₹
Shares outstanding
119,55 млн
No. of employees
19 мың
Open
5 407,00 ₹
High
5 407,00 ₹
Low
5 239,00 ₹
Mkt. cap
620,82 млрд
Avg. vol.
148,86 м.
Volume
140,99 м.
Dividend
1,01%
Quarterly dividend
13,25 ₹
Ex-dividend date
2026 ж. 07 там.
P/E ratio
29,18
52-wk high
5 933,50 ₹
52-wk low
5 051,00 ₹
EPS
180,45 ₹
Shares outstanding
119,55 млн
No. of employees
19 мың
News stories
From web sources and news partners
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees19,3 мың
Founded1973
HeadquartersМумбаи, Махараштра, Үндістан
SectorPharmaceutical industry
Websitealkemlabs.com
Last report
2026 ж. 14 там.
Fiscal period
Q1 2027
43,49 ₹ / 47,04 ₹
-7,56%miss
Revenue / Est. (INR)
37,40 млрд / 37,96 млрд
-1,46%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
40,01 млрд
37,37 млрд
36,03 млрд
37,40 млрд
Cost of goods sold
14,01 млрд
12,73 млрд
14,33 млрд
12,01 млрд
Cost of revenue
14,01 млрд
12,73 млрд
14,33 млрд
12,01 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,10 млрд
7,22 млрд
17,12 млрд
8,09 млрд
Operating expense
17,73 млрд
17,31 млрд
17,80 млрд
18,73 млрд
Total operating expenses
31,74 млрд
30,04 млрд
32,13 млрд
30,74 млрд
Operating income
8,27 млрд
7,33 млрд
3,90 млрд
6,66 млрд
Other non operating income
1,04 млрд
1,43 млрд
-3,55 млрд
1,53 млрд
EBT including unusual items
8,95 млрд
7,81 млрд
4,22 млрд
7,71 млрд
EBT excluding unusual items
8,95 млрд
8,33 млрд
4,77 млрд
7,71 млрд
Income tax expense
1,16 млрд
1,28 млрд
1,71 млрд
2,50 млрд
Effective tax rate
12,98%
16,35%
40,53%
32,47%
Other operating expenses
9,69 млрд
9,15 млрд
-378,70 млн
9,64 млрд
Net income
7,65 млрд
6,36 млрд
2,36 млрд
5,20 млрд
Net profit margin
19,12%
17,02%
6,56%
13,90%
Earnings per share
63,99
56,88
26,50
43,49
Interest and investment income
-
-
3,92 млрд
-
Interest expense
-350,20 млн
-421,00 млн
-336,50 млн
-466,20 млн
Net interest expenses
-350,20 млн
-421,00 млн
3,58 млрд
-466,20 млн
Depreciation and amortization charges
936,10 млн
950,10 млн
1,06 млрд
1,00 млрд
EBITDA
9,18 млрд
8,11 млрд
4,67 млрд
7,43 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары